JPRN-UMIN000006685
Not yet recruiting
未知
Effect of tandospirone on cognition and social function in schizophrenia - Cognition and tandospirone
Department of Neuropsychiatry, University of Toyama0 sites80 target enrollmentStarted: November 7, 2011Last updated:
Conditionsschizophrenia
Overview
- Phase
- 未知
- Status
- Not yet recruiting
- Sponsor
- Department of Neuropsychiatry, University of Toyama
- Enrollment
- 80
Overview
Brief Summary
/A
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 60years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Suicide attempt within 6 months before entry 2\) Treated with a depot antipsychotic 3\) Prescribed anticholinergic drugs and/or tricyclic antidepressants 4\)Dependence on alcohol and/or illicit drugs 5\) past history of head injury and/or seizure 6\) IQ less than 75 7\) pregnant 8\) BACS and/or UPSA administered within past 6 months
Investigators
Similar Trials
Unknown
Phase 4
A Based on PEEG and PET Study of Anxiolytic Treatment to Improve Cognitive Function in Patients With Alzheimer DiseaseAlzheimer DiseaseCognitive FunctionNCT03151382Zhejiang Provincial People's Hospital30
Completed
Not Applicable
Effects of Hydrocortisone on Social Cognition and MemoryIndividualityNCT02478021Charite University, Berlin, Germany80
Terminated
Phase 4
Effects on Social and Cognition Functions of Blonanserin in First Episode Schizophrenia PatientsFirst Episode SchizophreniaSocial FunctionCognition FunctionBlonanserinNCT03784222Sumitomo Pharma (Suzhou) Co., Ltd.102
Completed
Not Applicable
Effects of Mineralocorticoid Receptor Stimulation on CognitionIndividualityNCT02478034Charite University, Berlin, Germany80
Recruiting
Phase 2
Investigating the effect of saffron on cognitive impairment in schizophrenic patients treated with electric shockSchizophrenia.SchizophreniaIRCT20240416061505N1Ahvaz University of Medical Sciences46